Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.73 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.73 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.60 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.60 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.124.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.124.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.620ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.620ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XYENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XYENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GP.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used